Guardant Health, Inc. (GH)
130.66
+0.54
(+0.42%)
USD |
NASDAQ |
Jun 10, 16:00
130.63
-0.03
(-0.02%)
After-Hours: 16:56
Guardant Health SG&A Expense (Quarterly) : 227.06M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 227.06M |
| December 31, 2025 | 204.32M |
| September 30, 2025 | 180.64M |
| June 30, 2025 | 169.85M |
| March 31, 2025 | 151.27M |
| December 31, 2024 | 156.64M |
| September 30, 2024 | 147.01M |
| June 30, 2024 | 122.33M |
| March 31, 2024 | 119.08M |
| December 31, 2023 | 116.79M |
| September 30, 2023 | 105.11M |
| June 30, 2023 | 112.56M |
| March 31, 2023 | 116.57M |
| December 31, 2022 | 119.31M |
| September 30, 2022 | 121.49M |
| June 30, 2022 | 117.28M |
| March 31, 2022 | 105.70M |
| December 31, 2021 | 99.87M |
| September 30, 2021 | 100.28M |
| Date | Value |
|---|---|
| June 30, 2021 | 96.09M |
| March 31, 2021 | 102.27M |
| December 31, 2020 | 100.79M |
| September 30, 2020 | 91.39M |
| June 30, 2020 | 62.20M |
| March 31, 2020 | 44.90M |
| December 31, 2019 | 41.15M |
| September 30, 2019 | 35.24M |
| June 30, 2019 | 32.88M |
| March 31, 2019 | 30.47M |
| December 31, 2018 | 29.66M |
| September 30, 2018 | 21.59M |
| June 30, 2018 | 20.57M |
| March 31, 2018 | 17.83M |
| December 31, 2017 | 18.35M |
| September 30, 2017 | 23.90M |
| June 30, 2017 | 14.60M |
| March 31, 2017 | 12.42M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 504.00M |
| Labcorp Holdings, Inc. | 551.00M |
| OPKO Health, Inc. | 48.61M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 89.57M |